Ginkgo Bioworks (DNA) Proxy Filing summary

Executive summary

• The 2025 Annual Meeting will be held virtually on June 12, 2025, with shareholders able to vote online, by phone, or by mail.

• Shareholders will vote on the election of seven directors, ratification of Deloitte & Touche LLP as auditor, and an advisory say-on-pay vote for executive compensation.

• The proxy statement details board composition, governance, compensation, audit matters, and related party transactions.

Voting matters and shareholder proposals

• Seven director nominees are up for election, with two elected by Class B shareholders and five by both Class A and B shareholders.

• Shareholders will ratify Deloitte & Touche LLP as the independent auditor for 2025.

• An advisory vote on executive compensation is included.

• Shareholder proposals for the 2026 meeting must be submitted between February 12 and March 14, 2026.

Board of directors and corporate governance

• The board will reduce from nine to seven members after the meeting.

• Board committees include Audit, Compensation, and Nominating & Corporate Governance, all comprised of independent directors.

• The board emphasizes diversity, tenure balance, and regular review of leadership structure.

• Shareholder engagement is ongoing through multiple channels, including direct employee engagement.